Before a packed house, speakers at MIT’s Aging Brain Initiative symposium described how immune system factors during aging contribute to Alzheimer’s, Parkinson’s and other conditions. The field is leveraging that knowledge to develop new therapies.
Understanding how interactions between the central nervous system and the immune system contribute to problems of aging, including Alzheimer’s, Parkinson’s disease, arthritis and more, can generate new leads for therapeutic development, speakers said at MIT’s symposium “The Neuro-Immune Axis and the Aging Brain” Sept 18.
